The most prevalent community-associated methicillin-resistant Staphylococcus aureus (C-MRSA) strains in Taiwan, sequence type 59 (ST59) clones, carry staphylococcal cassette chromosome mec (SCCmec) type V and, to a lesser extent, type IV. These strains show wide variation in sensitivity to oxacillin, but the reasons for this variation are unknown. Here we compared the sequences of the mecA genes from clinical strains of different SCCmec types and found that they contain different mecA promoter mutations. Analysis of mecA promoter activity by reporter gene fusions showed that single base substitutions in the promoter have a strong influence on mecA transcription. The different mecA variants, including promoter sequences, were expressed in the methicillin-sensitive Staphylococcus aureus (MSSA) strain C195 (ST59 background). PBP 2a production among the parental strains and strains with promoter mutant mecA genes showed a close correlation with mecA transcription levels. Furthermore, the quantity of PBP 2a also closely correlated with the level of oxacillin resistance in the C195 background. Our data suggest that mecA promoter mutations play an important role in determining the level of oxacillin resistance. The mecA promoter mutation G-25A (25 bases upstream of the mecA translation start site) was found to be associated with a high oxacillin MIC (256 g/ml), G-7T conferred a moderate oxacillin MIC (32 to 64 g/ml), strains with C-33T showed a low oxacillin MIC (4 to 8 g/ml), and A-38G reversed the effect of the C-33T mutation, restoring the oxacillin resistance level in the A-38G C-33T double mutant. These observations may explain why C-MRSA strains in Taiwan carrying SCCmec type IV or V have such enormous variations in oxacillin MICs.
C ommunity-associated methicillin-resistant Staphylococcus aureus (C-MRSA) infections emerged in the late 1990s and have increased dramatically over the past several years (1, 2) . The changing epidemiology of MRSA has become one of the most important public health concerns worldwide (3) .
The most prevalent C-MRSA strains in Taiwan, sequence type 59 (ST59) clones, mostly carry staphylococcal cassette chromosome mec (SCCmec) type V (SCCmec V) and are pvl positive, while the pvl-negative ST59 MRSA clones mostly carry SCCmec IV (4-7). The epidemiological factors that have contributed to the dissemination of ST59 clones in Taiwan are not well understood. However, we recently identified a pvl-positive ST59-SCCmec V clone with borderline resistance to oxacillin that is the major contributor to a low-level oxacillin-resistant mecA-positive phenotype, which may provide a clue to ST59 prevalence (7, 8) .
MRSA strains are resistant to ␤-lactams in two ways: by production of penicillinase, which hydrolyzes the penicillin ␤-lactams but not semisynthetic penicillins, and by production of an altered penicillin-binding protein (PBP), PBP 2a (or PBP 2=), with a lower binding affinity for ␤-lactams, resulting in resistance to virtually all available ␤-lactam drugs (9) but not to the latest cephalosporins, such as ceftaroline (10) . Penicillinase is encoded by the blaZ gene, and PBP 2a is encoded by the mecA gene, located in the SCCmec element. Transcription of mecA and blaZ is usually regulated by their cognate regulators, mecR1 (sensor-signal transducer)-mecI (repressor) and blaR1-blaI, respectively (11) (12) (13) , but MecI and BlaI can each repress transcription of the other gene (i.e., blaZ and mecA, respectively) (14) . However, although there is a functional overlap between the repressors, the corresponding sensor-transducer molecules, MecR1 and BlaR1, work only with their respective repressors (15) . Moreover, if the mecR1-mecI regulatory elements are absent or truncated, the control of mecA expression is then carried out by the structurally similar blaR1-blaI regulators (16, 17) ; indeed, this is the case for SCCmec types IV and V, whose mecR1-mecI regulatory elements are disrupted by IS1272 and IS431, respectively (18, 19) .
In Switzerland, a MRSA strain with low-level oxacillin resistance (0.5 to 4 g/ml) is spreading among intravenous drug users (20) . This so-called drug clone has the ability to generate highly resistant subclones. A recent study found that although mecA promoter mutations have a significant influence on the levels of mecA transcription and PBP 2a in this clone, they have little effect on the level of ␤-lactam resistance. Rather, the genetic background of the strain appears to play the major role in governing the level of ␤-lactam resistance (17) .
There is wide variation in the level of oxacillin resistance (MIC range, 1 to Ͼ256 g/ml) of mecA-positive ST59 isolates in Taiwan (7, 8) , but the reasons for this variation are unknown. The present study investigated the impact of polymorphisms in the mecA gene from four SCCmec types on the level of oxacillin resistance in an ST59 clinical S. aureus genetic background.
MATERIALS AND METHODS
Bacterial strains. The bacterial strains and plasmids used in this study are listed in Table 1 . Unless stated otherwise, Luria-Bertani (LB) broth and plates were used for growth of Escherichia coli and S. aureus at 37°C. E. coli strain XL10-Gold (Stratagene, La Jolla, CA) was used for cloning. S. aureus cells were transformed by electroporation, as described previously (21) . Ampicillin (100 g/ml) and chloramphenicol (5 g/ml) were used for plasmid selection in E. coli and S. aureus.
Antimicrobial susceptibility testing.
MICs for all S. aureus clinical strains were determined by broth microdilution (BMD) using a customdesigned Sensititre panel (Trek Diagnostic system; Thermo Fisher Scientific, East Grinstead, United Kingdom). The MICs of antibiotics were also determined for certain strains and constructs by Etest (AB Biodisk, Solna, Sweden) or BMD (22) . The BMD method was performed in MuellerHinton II broth (MHB; containing 2% NaCl for oxacillin-containing wells) from an inoculum of 5 ϫ 10 5 CFU/ml, and the MIC was read after incubation at 35°C for 24 h. S. aureus ATCC 29213 and ATCC 43300 were used for quality control.
Determination of mecA polymorphisms by sequencing. Seventeen clinical MRSA strains from our previous study (5, 7) were chosen for mecA gene sequencing, including one SCCmec II isolate, two SCCmec III isolates, six SCCmec IV isolates, and eight SCCmec V isolates (see Table 3 ). Additional SCCmec type IV and V clinical isolates were included because they exhibited more diverse oxacillin MIC values on the basis of Etest results.
Production of mouse monoclonal anti-PBP 2a antibody. The mecA gene without the first 23 amino acids of the transmembrane anchor (23) was cloned by PCR from S. aureus clinical strain C027 into the pET-41 Ek/LIC vector using the LIC-specific primers LIC-mecA-F and LICmecA-R (Table 2 ), according to the manufacturer's instructions. The resulting fusion protein carried N-terminal glutathione S-transferase (GST), S-tag, and His-tag sequences from the pET-41 vector. The recombinant plasmid was transformed into E. coli NovaBlue and then BL21(DE3) cells (Novagen, Madison, WI). Protein was produced on the basis of Studier's autoinduction method (24) . Briefly, cells were grown in 3 ml ZYM-5052 medium containing 50 g/ml kanamycin for 2 h at 37°C with agitation (250 rpm) and then poured into 100 ml of fresh medium in 500-ml flasks and incubated for 2 h at 37°C and then for an additional 20 h at 26°C. Cell pellets were lysed with BugBuster protein extraction reagent (Novagen, Madison, WI) and then centrifuged to remove the debris. The recombinant His-tagged fusion protein in the supernatant was purified by using a HisTrap affinity column according to the manufacturer's instructions (GE Healthcare, Piscataway, NJ). Tag-free recombinant PBP 2a was eluted from the HisTrap column after cleavage by recombinant enterokinase (Novagen, Madison, WI). Mouse monoclonal anti-PBP 2a antibodies were generated commercially by Genesis Biotech Inc. (Taipei, Taiwan) using the purified tag-free recombinant PBP 2a from this study.
Western blot analysis for PBP 2a detection. For detection of PBP 2a, strains or transformants were adjusted to a 0.5 McFarland turbidity in 0.85% NaCl and then diluted 1:100 in 30 ml MHB containing chloramphenicol, as appropriate, and incubated at 37°C with shaking at 180 rpm to allow the cells to reach an optical density (OD) at 600 nm (OD 600 ) of 1. Cells were harvested, washed, and then disrupted in a Fastprep-24 homogenizer with Lysing Matrix B (MP Biomedicals, Solon, OH). The samples were centrifuged for 5 min at 12,000 ϫ g to remove unbroken cells and debris, and the total protein concentration was determined by a Bradford protein assay (Bio-Rad Laboratories, Richmond, CA). Protein samples (1 g of protein per lane) were subjected to 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then transferred to a polyvinylidene difluoride membrane (Immobilon; Millipore Corp., Bedford, MA). The membrane was blocked with 5% skim milk in phosphate-buffered saline with 0.05% Tween 20 (PBST), followed by blocking with human IgG (Sigma-Aldrich, St. Louis, MO) at 1:6,000 in 1% skim milk. PBP 2a was probed with mouse monoclonal anti-PBP 2a antibody (2F6F), and sortase A, a transpeptidase, was used as an internal control and identified by rabbit polyclonal anti-sortase A primary antibody (Abcam Inc., Cambridge, MA). Band signals were visualized with horseradish peroxidase-conjugated secondary antibodies (Abcam Inc., Cambridge, MA), followed by Western Lightning chemiluminescence reagent plus (PerkinElmer Life Sciences, Boston, MA).
Construction of mecA promoter-reporter plasmids. For stable bioluminescence activity controlled by a strong promoter within an optimal transcriptional reporter vector, the luxABCDE reporter was reconstructed using primers which incorporated three stop codons in three frames, a ribosome binding site upstream of the luxA gene, and a T 2 terminator of the E. coli rrnB gene (25) downstream of the luxE gene ( Table 2 ). The luxABCDE operon was amplified by PCR from plasmid pFJC0601 (26) , digested with SalI and PvuII, and then cloned into pSK5630 (27) to generate the transcriptional fusion vector pluxT2. The mecA promoter fragment was PCR amplified from the chromosomes of five clinical strains, V070 (SCCmec II), M088 (SCCmec III), C103 (SCCmec IV), M183 (SCCmec V), and C027 (SCCmec V), using the primers P mecA -F and P mecA -R. These amplified mecA promoter fragments were fused upstream of the lux reporter genes of pluxT2 using the BamHI and SalI sites, respectively, and the resulting plasmids were used for transformation of S. aureus strain RN4220 and then strains RN6390B and C195 (a pvl-positive ST59 methicillin-sensitive Staphylococcus aureus [MSSA] strain). The resulting mecA promoter-reporter fusion constructs were confirmed by restriction enzyme analysis and DNA sequencing.
Luciferase reporter assays. Bioluminescence measurements were performed using a TopCount NXT system (Perkin-Elmer Biosystems) to determine the transcriptional level of the mecA promoter constructs. Three independent transformants harboring promoter-reporter fusion plasmids were grown overnight with shaking at 37°C in tryptic soy broth (TSB) containing chloramphenicol for reporter plasmid maintenance, diluted 1:100 in the same medium, grown for an additional 2 h, and then diluted 10-fold in the same medium supplemented with 0.02 g/ml oxacillin, as appropriate for induction. Aliquots (200 l) of the cultures were transferred into 96-well plates in duplicate and incubated at 37°C. Both OD 595 and bioluminescence (in relative light units [RLU]) were monitored every hour for 7 h.
Cloning of the mecA gene. The mecA gene and its promoter were amplified from S. aureus clinical strains V070 (SCCmec II), M088 (SCCmec III), C103 (SCCmec IV), M183 (SCCmec V), and C027 (SCCmec V) by PCR using the primers mecA-F and mecA-R ( Table 2 ). The DNA fragments were digested and cloned into the HindIII and PvuII sites of pSK5630. The resulting constructs were confirmed by restriction enzyme analysis and DNA sequencing. These mecA gene-containing plasmids were then electroporated into RN4220 and then C195 cells. Oxacillin and cefoxitin MICs were determined for three independent transformants by BMD using MHB containing chloramphenicol and 2% NaCl for oxacillin-containing wells.
Probing the mecA gene by site-directed mutagenesis. To evaluate the effect of mecA polymorphisms on oxacillin resistance, site-directed mutagenesis was performed by PCR (28) on pM088mecA template plasmid DNA using the primers described in Table 2 . After PCR using the mutant primers, mecA promoter mutants were treated with DpnI, ligated into a circle with T4 DNA ligase, and then used to transform XL10-Gold cells. Mutagenesis of the mecA coding sequence was performed with a QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA) according to the manufacturer's instructions. Whole mecA genes were then cloned from the mutated plasmids into pSK5630 again to eliminate potential mutation of the vector sequence. The resulting mutants were confirmed by restriction enzyme analysis and DNA sequencing. These mecA gene mutant plasmids were then electroporated into RN4220 and then C195 cells. Oxacillin and cefoxitin MICs were determined for three independent transformants by BMD, as described above.
RESULTS

Correlation of mecA polymorphisms and oxacillin resistance.
The mecA genes from 17 clinical MRSA strains were found to have polymorphisms in promoter and/or coding sequences (Table 3) , but the promoter region was especially polymorphic: each SCCmec type, except for SCCmec III (whose promoter sequence is the same as the consensus sequence), can be characterized by promoter sequences that differ by one or two unique base substitutions (Table 3 ). The mecA promoter in the single SCCmec II strain examined has a G-to-A substitution located at 25 bp upstream (position Ϫ25) of the mecA translation start site. Three of the six SCCmec IV strains (C103, M153, and V043) have a G-to-T substitution in the ribosomal binding site (position Ϫ7), thus distinguishing two classes of promoter sequence in this SCCmec type. Similarly, the mecA promoter of the seven SCCmec V strains can be divided into two classes: all seven strains have a C-to-T substitution at Ϫ33, while three of the strains have an additional A-to-G substitution at position Ϫ38.
The highest concentration of oxacillin in our Sensititre panel used in this study was 4 g/ml; therefore, the oxacillin MIC of these 17 isolates was also determined by Etest (Table 3 ). The single SCCmec II and two SCCmec III strains tested all had oxacillin MICs of Ͼ256 g/ml. In contrast, the seven SCCmec IV strains had a range of oxacillin MICs, from moderate values (48 to 64 g/ml) to high values (256 g/ml). Among the SCCmec V strains, those possessing only the C-33T substitution in the promoter showed low oxacillin resistance (1.5 to 16 g/ml). To assess the (Fig. 1) . Variable activity of mecA promoters. The different levels of PBP 2a production observed for the different promoter sequences suggested that mecA transcription could be influenced by certain mutations within the mecA promoter. To assess promoter activity directly, mecA promoters from V070 (SCCmec II), M088 (SCCmec III), C103 (SCCmec IV), M183 (SCCmec V), and C027 (SCCmec V) were cloned upstream of the luxABCDE reporter gene cluster to create promoter-reporter gene fusion constructs. The transcriptional activity of the mecA promoter variants was compared in strains C195 and RN6390B; the former strain contains a ␤-lactamase plasmid (encoding the BlaI repressor of mecA transcription), and the latter does not. A bioluminescent assay was performed to determine the transcriptional levels driven by the mecA promoters (Fig. 2) . In the absence of the BlaI repressor (RN6390B background), the mecA promoter is constitutively expressed, as illustrated in Fig. 2A . The V070 promoter (P V070 , G-25A) had higher promoter activity than the M088 promoter (P M088 ). In contrast, the C027 promoter (P C027 , C-33T) had the lowest promoter activity, producing only minor bioluminescence ( Fig. 2A) . The C103 promoter (P C103 , G-7T) had moderate promoter activity, whereas the M183 promoter (P M183 , C-33T/A-38G) had promoter activity similar to that of P M088 . Even though P C103 carries a single substitution (G-7T) in the ribosomal binding site of mecA, the reporter assay indicated that this substitution was still able to cause a reduction in mecA transcription (note that our transcriptional fusion vector pluxT2 carries its own ribosomebinding site upstream of the luxA gene, so the observed reduction in reporter gene activity caused by the G-7T mutation was unlikely due to a protein translation problem but, rather, was due to an effect on transcription). In addition to the mecA promoter variants, we also investigated the effect of the single A-38G substitution found in P M183 . A P M088 A-38G mutant promoter was constructed by site-directed mutagenesis and found to have the highest promoter activity of all the mutants examined ( Fig. 2A) . In the presence of the BlaI repressor (C195 background), mecA promoter activity was strongly repressed by the BlaI repressor without induction, and only the P V070 and P M088 A-38G promoters retained moderate promoter activity (Fig. 2B) . The activities of the other promoters appeared to parallel the time curve, indicating that repression of mecA transcription by the BlaI repressor is stronger than mecA promoter activity.
The BlaI repressor could be cleaved by the BlaR1 sensor-transducer upon induction by a ␤-lactam to allow transcription of mecA. For the induction assay, an optimal concentration of 0.02 g/ml oxacillin was determined; this concentration had a minimal effect on bacterial growth and maintained inducer activity. The bioluminescent assay again showed that, upon oxacillin induction in the C195 background, these promoters had orders of activity similar to what they showed in the RN6390B background (Fig. 2C) . There was maximum bioluminescence after 2 h of induction, and thereafter, the mecA promoter activity was strongly repressed by the BlaI repressor, as illustrated in Fig. 2C . Again, P M088 A-38G proved to be an extraordinarily strong promoter in the C195 strain upon induction, directing approximately 30-fold more transcription than did P C027 (P M088 A-38G, 18,220 Ϯ 920 RLU; P C027 , 617 Ϯ 76 RLU; Fig. 2C ). The ODs of all strains were monitored simultaneously, and there were no significant differences (data not shown). Therefore, there is a positive correlation between mecA promoter activity and the level of PBP 2a production.
Impact of mecA genes on oxacillin resistance level. 
a Strain names highlighted in bold were chosen for further study. tance levels and PBP 2a production in the isogenic background of the pvl-positive ST59 MSSA strain C195. We found that the oxacillin MICs of some transformants were difficult to interpret because there was a thin layer of growth in the ellipse area around the Etest strips. Therefore, the following oxacillin MICs were determined by BMD, including those of the parental clinical strains. In addition, to provide additional data regarding the impact of mecA polymorphisms, we also obtained cefoxitin MICs by BMD. The oxacillin MICs of the parental clinical strains determined by the Etest and BMD methods were comparable, except for those for strains M088 and M183. Both of the last two strains had oxacillin MICs of Ͼ256 g/ml by Etest but only 128 g/ml by the BMD method ( Table 4 ). The levels of oxacillin resistance and PBP 2a expression of these mecA genes in the C195 background were similar to those of their respective parental clinical MRSA strains (Table 4 and Fig. 3) . However, major relevant differences in oxacillin MICs were seen between the C027 clinical strain and pC027mecA/C195 transformants, in which the MIC of the former was in the susceptible range (2 g/ml) and that of the latter was in the resistant range (8 g/ml). In contrast, the C027 clinical strain and pC027mecA/ C195 transformants all had cefoxitin MICs in the resistant range (16 g/ml). PBP 2a production quantified by Western blotting showed that the pV070mecA/C195 transformants yielded larger amounts of PBP 2a, followed by the amounts for the pM088mecA/ C195 and pM183mecA/C195 transformants, both of which had moderate levels of PBP 2a production. In contrast, the level of PBP 2a expression in the pC103mecA/C195 and pC027mecA/C195 transformants was much lower, especially in the latter, which had only a residual PBP 2a signal (Fig. 3A) . Besides the pvl-positive ST59 MSSA strain C195 genetic background, we also wanted to test the effects of these mecA genes in other genetic backgrounds. Therefore, we transferred these mecA genes into another MSSA clinical strain, KSM144 (29) , representative of the diverse ST6 genetic background. The oxacillin and cefoxitin resistance levels conferred by these mecA genes in the KSM144 background were similar to those conferred in the C195 background (Table 4) .
Probing the effects of mecA gene variants on oxacillin resistance level. To clarify the effects of nucleotide substitutions in the mecA promoter on oxacillin resistance in the C195 background, site-directed mutagenesis was performed on the pM088mecA plasmid, which carries the mecA promoter consensus sequence. In addition to oxacillin susceptibility testing, Western blot analyses were performed to evaluate the contribution of individual nucleotide substitutions to PBP 2a production (Fig. 3B) . PBP 2a was produced in larger amounts in pM088mecA G-25A/C195 and pM088mecA A-38G/C195 than in pM088mecA, especially in the pM088mecA A-38G/C195 mutant, which had the largest amount of PBP 2a. The single base mutation in the ribosomal binding site of pM088mecA (pM088mecA G-7T/C195) caused a significant reduction in expression of PBP 2a. In addition, transformants carrying a C-to-T single base mutation 33 bp upstream (position Ϫ33) of the mecA translation start site (pM088mecA C-33T/C195) expressed only a residual amount of PBP 2a. Remarkably, an additional A-to-G mutation located at position Ϫ38 (pM088mecA C-33T, A-38G/C195) reversed the effect of the C-33T mutation, restoring the expression of PBP 2a to a level similar to that of pM088mecA.
The oxacillin resistance levels of these pM088mecA sited-directed promoter mutants in a C195 background were similar to those of the original mecA promoter mutants on which they were based (Table 4) . For example, pM088mecA C-33T/C195 shared the same promoter sequence with pC027mecA/C195, and both exhibited similar low levels of oxacillin resistance. In contrast, site-directed mutations in the mecA coding sequence of the pM088mecA plasmid had little or no effect on oxacillin resistance, with only pM088mecA A438T/C195 and pM088mecA G612T/ C195 showing minor variability in oxacillin resistance (Table 4) . Thus, these results demonstrate that the promoter sequence mutations but not the coding sequence mutations exert important effects on oxacillin resistance. To confirm the effects of the mecA coding sequence mutations, we also performed site-directed mutagenesis on the mecA coding sequence of the pM183mecA plasmid to determine the contributions of positions 438 and 612 to oxacillin resistance. The resulting mutants, pM183mecA T438A/ C195, pM183mecA T612G/C195, pM183mecA A675T/C195, and pM183mecA G737A/C195, all showed oxacillin resistance levels comparable to the level for pM183mecA/C195 (128 g/ml). In contrast to oxacillin resistance, the cefoxitin resistance levels of the wild type and the mutants with mutations in the mecA genes in a C195 background exhibited narrow variation (16 to 128 g/ml) ( Table 4) .
DISCUSSION
Although polymorphisms in the mecA gene from clinical isolates have been described previously (30), their correlation with the level of ␤-lactam resistance has not been proven. In addition, a number of factors have also been reported to affect the level of methicillin resistance in mecA-positive S. aureus. Chromosomal factors, such as fem (factors essential for methicillin resistance), aux (auxiliary), and the VraS/VraR two-component regulatory system (31, 32) , and environmental factors, such as temperature and salt concentration, have all been shown to influence the level of methicillin resistance (9) . The loss of PBP 4 has been shown to cause a reduction in resistance to ␤-lactams in the most common C-MRSA strains in the United States but not in hospital-associated MRSA (H-MRSA) strains (33) . A recent study found that although mecA promoter mutations have a significant influence on the levels of mecA transcription and PBP 2a in a so-called drug clone, they have little effect on the level of ␤-lactam resistance. Rather, the genetic background of the strain appeared to play the major role in governing the level of ␤-lactam resistance (17) . Their results concurred with previous conclusions, that there is no direct correlation between the level of ␤-lactam resistance and the quantity of PBP 2a (34) . Therefore, the regulation of methicillin resistance in mecA-positive S. aureus is complex and remains to be elucidated (35) .
In the present study, sequences of the mecA gene from clinical strains with different SCCmec types revealed that they contain variable mecA promoter substitutions, which appear to correlate with their oxacillin MICs. Analysis of mecA promoter-reporter gene fusion constructs showed that different mecA promoter substitutions can indeed have a significant influence on mecA transcription, especially a C-to-T mutation 33 bp upstream (position Ϫ33) of the mecA translation start site. This C-to-T substitution, localized in the Ϫ10 hexamer region of the mecA promoter, is identical to that in various SCCmec V isolates and drug clone CHE482 (17, 18, 36) . The majority of these isolates have low-level oxacillin-resistant phenotypes. In the absence of the BlaI repressor, P C027 (C-33T) exhibited minimal promoter activity, indicating that this substitution allows only relatively low-level transcription in S. aureus unassociated with the binding affinity of the BlaI repressor. Some of our SCCmec V isolates had an additional Ato-G substitution at position Ϫ38 within the Ϫ10 hexamer and the binding site of the BlaI repressor. Because this substitution could increase mecA transcription, it thereby compensated for the loss of mecA promoter activity caused by the C-33T substitution. Another substitution, G-25A in an SCCmec II strain, seemed to have a similar effect on mecA transcription as the A-38G substitution; strains with both of these types of substitutions had equivalent transcriptional profiles. A nucleotide substitution at position Ϫ7, which is located in the ribosomal binding site of mecA and which occurs more commonly in SCCmec IV strains (30) , also caused downregulation of promoter activity. The fact that a specific base within the ribosomal binding site could influence both promoter activity and downstream protein production is potentially very interesting.
In the present study, mecA gene variants, including promoter and coding region mutants, were cloned into a low-copy-number vector and expressed in an MSSA strain with an ST59 background to eliminate the influence of the genetic background of clinical strains on PBP 2a production and oxacillin resistance levels. Anal- a Antibiotic MICs were determined for three independent transformants on two separate days by BMD using MHB containing chloramphenicol and 2% NaCl for oxacillin-containing wells. Numbers in parentheses indicate the number of times that the particular antibiotic MIC was obtained.
ysis of PBP 2a production among the parental and promoter mutant mecA genes revealed a close positive correlation between PBP 2a production levels and mecA transcription levels. Furthermore, the quantity of PBP 2a was also closely correlated with the level of oxacillin resistance in a C195 background. Our results challenge previous conclusions that there is no direct correlation between the oxacillin MIC and amounts of PBP 2a (34) . This discrepancy may suggest that the C195 background has not yet acquired (unknown) factors outside the mecA gene that contribute to the phenotypic expression of resistance. A previous study by Katayama et al. showed that two mutations in the mecA coding sequence produced high-level resistance against ␤-lactams (37). However, this was investigated by passage of homogeneous MRSA strain COL in the presence of L-695,256, an investigational carbapenem. In contrast, polymorphisms in the mecA coding sequence from clinical isolates in the present study did not show obvious effects on oxacillin resistance levels. MRSA arises when MSSA acquires an SCCmec element, which contains the mecA gene encoding a PBP 2a with a lowered binding affinity for ␤-lactams (38) . Therefore, when some MSSA strains, such as C195 and KSM144, newly acquire SCCmec type IV or V, they may get one of four types of mecA promoter sequence. If a strain acquires a mecA gene with the consensus promoter sequence or the C-33T/A-38G substitution, it will have a high oxacillin MIC; with the G-7T substitution it will have a moderate oxacillin MIC, and with the C-33T substitution it will have a low oxacillin MIC. Another possibility is that a low-level-resistant clone with a C-33T substitution could become a highly resistant clone by acquiring an additional A-38G mutation upon exposure to ␤-lactam agents. Our results differ from those of a previous study (17) , in which mecA genes were introduced into the lowlevel-resistant strain CHE482 and the highly resistant strain COLn. Both strains may have carried extraneous chromosomal mutations contributing to the extremely low or high level of ␤-lactam resistance; therefore, resistance levels did not directly correlate with mecA transcription levels in that study. Similarly, in the present study, the SCCmec type V strain C027 was found to have an extremely low oxacillin MIC (Table 4) , which may be caused by extraneous chromosomal mutations, but this remains to be investigated. However, our results could explain the interesting observation that C-MRSA strains in Taiwan carrying SCCmec type IV or V have such enormous variations in oxacillin MICs.
